Cargando…
Identifying a prognostic model and screening of potential natural compounds for acute myeloid leukemia
BACKGROUND: Acute myeloid leukemia (AML) is one of the most common hematologic malignancies with a poor prognosis and high recurrence rate. The discovery of new predictive models and therapeutic agents plays a crucial role. METHODS: The differentially expressed gene that was explicitly highly expres...
Autores principales: | Sun, Xiao-Hong, Wan, Shun, Chai, Yi-Hong, Bai, Xiao-Teng, Li, Hong-Xing, Xi, Ya-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331709/ https://www.ncbi.nlm.nih.gov/pubmed/37434693 http://dx.doi.org/10.21037/tcr-22-2500 |
Ejemplares similares
-
Screening the Cancer Genome Atlas Database for Genes of Prognostic Value in Acute Myeloid Leukemia
por: Ni, Jie, et al.
Publicado: (2020) -
Nucleophosmin mutations confer an independent favorable prognostic impact in 869 pediatric patients with acute myeloid leukemia
por: Xu, Lu-Hong, et al.
Publicado: (2020) -
A cell-based large-scale screening of natural compounds for inhibitors of SARS-CoV-2
por: Zhang, Zhe-Rui, et al.
Publicado: (2020) -
Wilms Tumor 1 Mutations Are Independent Poor Prognostic Factors in Pediatric Acute Myeloid Leukemia
por: Wang, Yin, et al.
Publicado: (2021) -
m5C methylation modification guides the prognostic value and immune landscapes in acute myeloid leukemia
por: Liu, Ya, et al.
Publicado: (2023)